St. Jude Medical Announces New EnSite Precision Cardiac Mapping System Limited Market Release in Nine Countries Across Europe Since CE Mark

Go back to St. Jude Medical Announces New EnSite Precision Cardiac Mapping System Limited Market Release in Nine Countries Across Europe Since CE Mark

Needham & Company Raises Price Target on St. Jude Medical (STJ) Following Strong 1Q Results

April 20, 2016 1:14 PM EDT

Needham & Company reiterated a Strong Buy rating on St. Jude Medical (NYSE: STJ), and raised the price target to $75.00 (from $70.00), following the company's 1Q earnings report. STJ reported revenue of $1.448B, ahead of the consensus estimate of $1.436B. EPS was reported at $0.90 compared to consensus of $0.88.... More